Through PharmaDeal Financials PharmaPlus offers quick and affordable access to financial information on therapeutic license deals.

Knowledge of historical deal information is a crucial prerequisite for deal negotiations. PharmaDeal Financials are unique searchable thematic licensing databases. The databases feature deals over a 14 year period from a variety of companies, ranging from small company licensors to leading licensees like Pfizer, Novartis and GlaxoSmithKline. PharmaDeal Financial databases, which distinguish themselves by focusing on specific disease areas, indications and/or compound classes, only contain deals on therapeutics with at least one financial component. Each deal entry is categorized and searchable by licensor, licensee, indication, compound details, compound name, development stage (research – filed for regulatory approval), geographical territory, potential deal size, upfront, milestone payments, royalties on sales, research funding, equity and by year of deal establishment or any combination thereof. The databases can be downloaded directly on your desktop

Use of PharmaDeal Financials actually supported deal closure for clients that purchased the databases.

click here for the PharmaDeal Financials website.